Curelab Oncology Overview

  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

Curelab Oncology General Information

Description

Operator of a biotechnology company designed to create a family of revolutionary therapies for oncology patients in order to give prolong lives. The company's anti-cancer biologics offers immune stimulators and oncolytic virus for the treatment of cancer patients, enabling doctors to treat cancer effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Boston, MA
  • United States
+1 (609) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Curelab Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC Completed Startup
1. Grant 00.000 Completed Startup
To view Curelab Oncology’s complete valuation and funding history, request access »

Curelab Oncology Patents

Curelab Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210220437-A1 Compositions and methods relating to p62 for the treatment and prophylaxis of age-related macular degeneration Pending 02-Aug-2018 0000000000
AU-2014369861-B2 Methods and compositions relating to p62/sqstm1 for the treatment and prevention of inflammation-associated diseases Active 29-Dec-2013 00000000000 0
AU-2014369861-A1 Methods and compositions relating to p62/sqstm1 for the treatment and prevention of inflammation-associated diseases Granted 29-Dec-2013 00000000000
JP-2017502974-A Methods and compositions relating to p62 / sqstm1 for the treatment and prevention of inflammation-related diseases Granted 29-Dec-2013 00000000000 0
CA-2935232-A1 Methods and compositions relating to p62/sqstm1 for the treatment and prevention of inflammation-associated diseases Pending 29-Dec-2013 A61K39/0005

Curelab Oncology Executive Team (3)

Name Title Board Seat Contact Info
Alexander Shneider Ph.D Founder & Chief Executive Officer
Charles Legg Chief Operating Officer
Yuriy Oreshin General Director
To view Curelab Oncology’s complete executive team members history, request access »

Curelab Oncology Board Members (2)

Name Representing Role Since
Andrew Morozov Ph.D Self Board Member 000 0000
Michael Burns Curelab Oncology Board Member 000 0000
To view Curelab Oncology’s complete board members history, request access »

Curelab Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curelab Oncology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angelico Ventures Venture Capital Minority 000 0000 000000 0
Pharma 2020 Government 000 0000 000000 0
VEB Innovations Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Curelab Oncology’s complete investors history, request access »